Innovation Center’s Post

Meet The 45 Start-Ups! The conference offers a professional environment for ‘one-on-one’ meetings. Our online software enables the pre-setting and management of meetings; while at the same time enabling you to profile yourself in a way that will attract partners, investors and friends. The conference offers a professional environment for ‘one-on-one’ meetings. Our online software enables the pre-setting and management of meetings; while at the same time enabling you to profile yourself in a way that will attract partners, investors and friends. Unlock the Power of Ben-Gurion University's Research   As the Tech Transfer Company of Ben-Gurion University, we're excited to showcase our groundbreaking research to potential collaborators from the pharmaceutical, medical device, diagnostic, synthetic biology, and other related industries. Our cutting-edge academic research, combined with our unique bio-convergence approach, where biology meets engineering, provides a truly multidisciplinary solution to today's most pressing biological challenges. With BGU's esteemed engineering faculty, we're able to offer revolutionary, creative, and untraditional solutions. We're seeking visionary partners and collaborators to join us in further developing this research and bringing it to market. Contact us at anatsav@bgu.ac.il or visit us during the conference at DAVID INTERCONTINENTAL, room number 1125, 11th floor. CLICK HERE TO START NETWORKING >> https://bit.ly/3HrB7ID #BiomedIsreal #StartUp #Biomedical #AI #BioConvergence #BioFood #GeneTherapy #Robotics #DigitalHealth #InfectiousDisease #MedicalDevice #B2B #intercontinental

Attending Bio Integrates? Be sure to drop Josh a message so he can sit down with you and discuss how Quotient can support the acceleration of your candidates to clinic and beyond 🌟 #quotientsciences

After several rejections and resubmissions, we finally published this qualitative research on University–Industry Collaboration networks in the Journal of Technology Transfer (3* ABS). University–Industry Collaboration are increasingly significant to national economies. Previous studies have identified barriers and enablers of University–Industry Collaborations, however our understanding of the evolution of such collaborations is still limited thereby restricting our ability to nurture their development. This study explores the establishment of a successful University–Industry Collaboration and considers a range of perceived barriers and enablers through four emergent evolutionary phases: embryonic, initiation, engagement and established. The study adopted a qualitative research approach using a single site case study, focusing on the pharmaceutical industry. The results demonstrate that specific University–Industry Collaboration barriers and enablers emerge at different points in time, for example, strong lack of trust; strong fear of knowledge leakage, reluctance to share in the embryonic phase evolve to achieving integrity based trust and an intellectual property agreement in the engagement phase. These barriers were overcome using a range of phase appropriate mechanisms, for example, prior experience of the partners was critical in the embryonic phase, while cohesiveness and knowledge complementarity were vital in the engagement phase. This study emphasizes the significance of public funding and its distribution among members in order to support industry evolution and competitiveness. The University–Industry Collaboration continues to attract new participants and additional network-specific investments and has become a global centre of excellence for pharmaceutical research and development. #research #collaborativenetwork

Cultivating Excellence: How We Invest in Our People at Scientia Nova (Pvt Ltd) At Scientia Nova (Pvt Ltd), we understand that our greatest asset is our talented team. That's why we prioritize a comprehensive talent management strategy that fosters growth, engagement, and career development. Here's how we approach it: 🔷 Attracting Top Talent: 🔹 Competitive compensation & benefits: We offer competitive salaries, comprehensive benefits packages, and attractive career growth opportunities. 🔹 Diversity & inclusion: We actively build a diverse and inclusive work environment where everyone feels valued and empowered to contribute. 🔹 Meaningful work: We connect our team to the impact their work has on patients' lives, fostering a sense of purpose and motivation. 🔷 Developing Our Workforce: 🔹 Mentorship programs: We pair experienced researchers with early-career scientists for guidance and career development. 🔹 Professional development opportunities: We offer ongoing training programs, conferences, and workshops to help researchers hone their skills and stay current with advancements. 🔹 Leadership development: We invest in leadership training to empower researchers to take on new challenges and spearhead innovative projects. 🔷 Recognizing & Rewarding Excellence: 🔹 Performance recognition programs: We acknowledge and reward outstanding achievement, fostering a culture of continuous improvement. 🔹 Career advancement opportunities: We provide clear career pathways and support researchers in achieving their career goals. 🔹 Work-life balance: We promote a healthy work-life balance with flexible work arrangements and wellness initiatives. 🤝 Investing in Our People, Investing in Innovation 🙌 By prioritizing talent management, we create an environment where researchers can excel, reach their full potential, and contribute to groundbreaking discoveries. Let us know your thoughts on effective talent management strategies in the biomedical research industry? ☑ To avail our services or for any queries, please reach out through either of the following platforms. Our team will reach out to you soon! 📧 contact@scientianova.co.uk 🆔 https://lnkd.in/dE6Es6u2 🌐 www.scientianova.co.uk #biomedicalresearch #clinicalresearch #talentmanagement #workculture #careerdevelopment #growthmindset #diversityandinclusion #researchcareers #researchimpact #innovation #creativity #collaboration #learning #futureofmedicine #patientcare #researchimpact #researchresponse #innovation #vaccines #diagnostics #clinicaltrials #pandemicpreparedness #researchmetrics #efficiency #impactauthorship #drugdiscovery #researchskills #science #healthcare #researchtechnology #AI #bioinformatics #telemedicine #GCP #IRB #FDA #HIPAA #patientrights #researchintegrity #healthcare #clinicaltrials #medicine #surgery #research #pharmacy #publichealth

We are thrilled to announce the launch of our new Micro-certificate in Innovation Leadership: Medical & Bio-Innovations! 🎓✨ This program wouldn't have been possible without the incredible support and insights from our industry advisory committee and partners at the UBC Academy of Translational Medicine and UBC Extended Learning. Together, we've crafted a curriculum designed to meet the needs of the bioeconomy, ensuring participants gain the practical legal and strategic skills needed to bring scientific and technical innovations to market. This includes mastering effective IP strategies and identifying market gaps and addressing unmet healthcare needs. 🔬 Why This Program? As Canada's life sciences sector experiences unprecedented growth, the demand for skilled professionals who can successfully translate biomedical innovations from lab to market is more critical than ever. This part-time program offers a comprehensive understanding of the legal, technical, and market realities that influence the development and commercialization of new products and treatments. Through real-life case studies and instruction from industry experts, the program provides relevant, in-demand leadership and business skills needed to identify and act on future opportunities. A huge thank you to Novateur Ventures Inc. and all our industry collaborators who contributed to making this program a reality. Their insights have been invaluable in crafting a curriculum that not only addresses the immediate needs of the industry but also anticipates future trends. Participants will benefit from this deep industry engagement, gaining practical knowledge and strategies that are immediately applicable in their professional roles. To learn more and register, please visit: https://lnkd.in/gN3eeFWx Jonathon Jafari | entrepreneurship@UBC

As the United States expands public investment in technology-based industries like the life sciences, experts are examining how industrial policies could accelerate #innovation and protect the public. A new paper by James C. Robinson from the University of California, Berkeley argues that, in the face of ever-stronger competition, if the US is to retain its leading position in the life sciences, public policy must consider competition among nations as well as among firms. Robinson analyzes emerging innovation and policy in three sectors of the life sciences: research universities and laboratories, entrepreneurial startups and “scale-ups,” and large pharmaceutical and medical device corporations. Read the full article from the August issue of Health Affairs here: https://bit.ly/47oUxtw